Zi-Long Wang

Peking University - Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation

China

SCHOLARLY PAPERS

1

DOWNLOADS

41

TOTAL CITATIONS

2

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Genomic Landscape and Risk-Stratification for De Novo Acute Myeloid Leukemia with Normal Cytogenetics and No NPM1 or FLT3-ITD Mutation

Number of pages: 28 Posted: 03 Aug 2019
Ya-Lan Zhou, Li-Xin Wu, Robert Peter Gale, Zi-Long Wang, Jin-Lan Li, Hao Jiang, Qian Jiang, Bin Jiang, Shan-Bo Cao, Feng Lou, Ying Sun, Cheng-Cheng Wang, Ting Li, Yan-Rong Liu, Yu Wang, Ying-Jun Chang, Lan-Ping Xu, Xiao-Hui Zhang, Kai-Yan Liu, Guo-Rui Ruan and Xiao-Jun Huang
Peking University - Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University - Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Imperial College London, Peking University - Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University - Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University - Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University - Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University - Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, AcornMed Biotechnology Co., AcornMed Biotechnology Co., AcornMed Biotechnology Co., AcornMed Biotechnology Co., AcornMed Biotechnology Co., Peking University - Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University - Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University - People’s Hospital, Peking University - People’s Hospital, Peking University - People’s Hospital, Peking University - People’s Hospital, Peking University - People’s Hospital and Peking University - Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation
Downloads 41 (915,620)
Citation 2

Abstract:

Loading...

Acute myeloid leukemia, mutations, prognosis, targeted regional sequencing, measurable residual disease, risk stratification